Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Mar-Apr;6(2):117-27.
doi: 10.1593/neo.03205.

A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance

Affiliations

A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance

Ardith W El-Kareh et al. Neoplasia. 2004 Mar-Apr.

Abstract

A theoretical model for the intraperitoneal (i.p.) delivery of cisplatin and heat to tumor metastases in tissues adjacent to the peritoneal cavity is presented. The penetration distance (the depth to which drug diffuses directly from the cavity into tissues) is predicted to be on the order of 0.5 mm. The model shows that exchange with the microvasculature has more effect than cellular uptake in limiting the penetration distance. Possible effects of hyperthermia are simulated, including increased cell uptake of drug, increased cell kill at a given level of intracellular drug, and decreased microvascular density. The model suggests that the experimental finding of elevated intracellular platinum levels up to a depth of 3 to 5 mm when drug is delivered i.p. by a heated infusion solution is due to penetration of heat to this distance, causing increased cell uptake of drug. Beyond a depth of about 0.5 mm, the drug is delivered mainly through the circulation. Use of sodium thiosulfate to deactivate systemic cisplatin may therefore be counterproductive when heat is delivered locally. The model suggests that i.p. delivery of heat, combined with systemic delivery of drug, may be as effective as i.p. delivery of heat and drug.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Plasma concentration of (ultrafilterable) platinum after i.p. infusion. Line: theoretical model for ovarian carcinoma cells. Filled circles: experimental data for rat from Ref. [40].
Figure 2
Figure 2
Predictions of the mathematical model for rat, with ovarian carcinoma cells, without hyperthermia. Solid lines: normal tumor perfusion (vessel surface density Sv = 70 cm-1). Dashed lines: low tumor perfusion, represented by reduced surface density (Sv = 7 cm-1). Dashed-dotted lines: zero tumor perfusion. Dotted lines: with sodium thiosulfate administered intravenously, assumed to deactivate all circulating cisplatin. (A) Peak extracellular concentration in tumor as a function of position. The peak value is reached at different times at different points, so this curve is not a concentration profile at one instant in time. (B) Peak intracellular concentration in tumor as a function of position. (C) Survival fraction of cancer cells.
Figure 3
Figure 3
Predictions of mathematical model as in Figure 2, but with regional hyperthermia (i.e., all tissues adjacent to the peritoneal cavity heated to a uniform 43 C). Solid lines: normal tumor perfusion. Dashed lines: low tumor perfusion. Dashed-dotted lines: zero tumor perfusion. Dotted lines: normal tumor perfusion without heating, as shown in Figure 2.
Figure 4
Figure 4
Predictions of theoretical model for penetration of heat into the tumor tissues adjacent to the peritoneal cavity. The cavity is assumed to be at a constant temperature of either 42°C or 43°C for 90 minutes, after which it returns to 37°C. The cases of normal, low, and zero tumor perfusion are shown. Except for the case of wb = 0, all profiles are steady state reached after approximately 5 to 10 minutes.
Figure 5
Figure 5
Predictions of mathematical model as in Figure 2, but with i.p. hyperthermia, achieved by infusing the peritoneal cavity with a solution at 43°C. Solid lines: normal tumor perfusion. Dashed lines: low tumor perfusion. Dashed-dotted lines: zero tumor perfusion. Dotted lines: normal tumor perfusion without heating, as shown in Figure 2.

Similar articles

Cited by

References

    1. Akyurekli D, Gerig LH, Raaphorst GP. Changes in muscle blood flow distribution during hyperthermia. Int J Hypertherm. 1997;13:481–496. - PubMed
    1. Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med. 1996;335:1950–1955. - PubMed
    1. Bartlett DL, Buell JF, Libutti SK, Reed E, Lee KB, Figg WD, Venzon DJ, Alexander HR. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis. Cancer. 1998;83:1251–1261. - PubMed
    1. Blakley BW, Cohen JI, Doolittle ND, Muldoon LL, Campbell KC, Dickey DT, Neuwelt DT. Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001. Laryngoscope. 2002;112:1997–2001. - PubMed
    1. Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg. 2000;87:1006–1015. - PubMed

Publication types

LinkOut - more resources